These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3729496

  • 1. [Induction of mouse peritoneal cytotoxic factor by OK-432. (3). Comparison between LPS and OK-432 as eliciting agents].
    Yamamoto A, Nagamuta M, Usami H, Sugawara Y, Nishii Y, Suzuki S, Watanabe N, Niitsu Y, Urushizaki I.
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2419-24. PubMed ID: 3729496
    [Abstract] [Full Text] [Related]

  • 2. [Induction of a cytotoxic factor into the peritoneal fluid (PCF) by OK-432. II. Physicochemical and immunological characteristics of PCF].
    Nagamuta M, Yamamoto A, Usami H, Sugawara Y, Nishii Y, Watanabe N, Niitsu Y, Urushizaki I.
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2358-62. PubMed ID: 3488030
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation.
    Yamamoto A, Nagamuta M, Usami H, Sugawara Y, Watanabe N, Niitsu Y, Urushizaki I.
    Immunopharmacology; 1986 Apr; 11(2):79-86. PubMed ID: 3710767
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of a cytotoxic factor induced in mouse peritoneal fluid by OK-432.
    Nagamuta M, Yamamoto A, Usami H, Sugawara Y, Watanabe N, Niitsu Y, Urushizaki I.
    Immunol Lett; 1986 Aug; 13(1-2):101-5. PubMed ID: 3759145
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T.
    Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
    [Abstract] [Full Text] [Related]

  • 12. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
    Saito M, Aonuma E, Noda T, Nakadate I, Nanjo M, Ebina T, Ishida N.
    Gan To Kagaku Ryoho; 1983 May; 10(5):1363-71. PubMed ID: 6870302
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic effect of OK-432 induced endogenous TNF on tumor bearing mice and cancer patients.
    Watanabe N, Niitsu Y, Yamauchi N, Neda H, Sone H, Urushizaki I, Yamamoto A, Nagamuta M, Sugawara Y.
    Immunopharmacol Immunotoxicol; 1988 May; 10(1):53-65. PubMed ID: 3361071
    [Abstract] [Full Text] [Related]

  • 14. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
    Ujiie T.
    Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
    [Abstract] [Full Text] [Related]

  • 15. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)].
    Saito M, Yamaguchi T, Aonuma E, Noda T, Edina T, Ishida N.
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):2031-7. PubMed ID: 6820888
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Induction of interferon-gamma and tumor necrosis factor in ascites of a patient with ovarian cancer by OK-432.
    Mori H, Itoh N, Shiraki S, Tamaya T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):497-8. PubMed ID: 3131464
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Nakamori M, Ueda K, Naka T, Katsuda M, Miyazawa M, Iida T, Yamaue H.
    Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.